Creo Medical Group PLC (AIM:CREO)

Market Cap	50.31M
Revenue (ttm)	4.00M
Net Income (ttm)	-28.70M
Shares Out	402.47M
EPS (ttm)	-0.08
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	172,454
Average Volume	341,583
Open	12.75
Previous Close	12.50
Day's Range	12.25 - 12.75
52-Week Range	9.22 - 37.00
Beta	0.54
RSI	43.41
Earnings Date	Sep 9, 2025

About Creo Medical Group

Creo Medical Group PLC, through its subsidiaries, engages in the research, development, manufacture, and sale of medical devices and instruments for clinics and hospitals in the United Kingdom. It is developing CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with controllable devices delivered through an endoscope. The company also offers Speedboat Inject, an energy multimodal instrument for endoscopy; MicroBlate Fine, a microwave...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2003
• Employees: 129
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: CREO

Financial Performance

In 2024, Creo Medical Group's revenue was 4.00 million, a change of 0.00% compared to the previous year's 4.00 million. Losses were -28.70 million, 32.3% more than in 2023.